• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 11-11-2025: Press Release

    11-11-2025 | 09:53 am

    Zydus Lifesciences gained approval for Venlafaxine Extended-Release Capsules (75mg & 150mg) in China. This marks their first product approval for the Chinese market, expanding reach for their antidepressant and anti-anxiety medication.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited